“…Disease severity, which was not reported in eight studies (Agostino et al, 2004;Lee et al, 2019;Leow et al, 2012;Mochizuki-Kawai et al, 2010;Nutt et al, 2000;Roy et al, 2015;Simley-Oyen et al, 2002;Smiley-Oyen et al, 2003), ranged from I to IV on the Hoehn & Yahr scale. The mean overall scores of the motor evaluation conducted with the UPDRS part III, which was reported in 22 studies (Agostino et al, 2004;Dan et al, 2015;Isaias et al, 2011;Kawashima et al, 2018;Lahlou et al, 2022;Lee et al, 2019;Leow et al, 2012;Lin et al, 2007;Marinelli et al, 2017b;Nackaerts et al, 2020;Nelson et al, 2017;Nicastro et al, 2018;Pendt et al, 2012;Pendt et al, 2011;Peterson et al, 2016;Roy et al, 2015;Sehm et al, 2014;Sidaway et al, 2016;Van Ooteghem et al, 2017;Whitfield and Goberman, 2017), ranged from 8 to 33.4, indicating that the severity of motor symptoms of patients ranged from mild to moderate (Hentz et al, 2015;Martínez-Martín et al, 2015). Disease duration, which was reported in all but seven studies (Dantas et al, 2018;Marinelli et al, 2017b;Mochizuki-Kawai et al, 2010;Sato et al, 2014;Sidaway et al, 2016;Simley-Oyen et al, 2002;Smiley-Oyen et al, 2003)…”